Richland WA, Feb. 06, 2020 (GLOBE NEWSWIRE) --

Vivos Inc. (OTCQB: RDGL), Vivos today announced that the University of Missouri College of Veterinary Medicine will be the first Isopet® regional clinic. The Isopet® therapy will now be included as a treatment option within their extensive veterinary cancer therapy portfolio. Following our recently completed clinical study of Isopet® at the University of Missouri’s College of Veterinary Medicine, we are excited to announce that they have agreed to offer Isopet® as a commercially available therapy option. This makes MU the first regional center to offer Isopet® in addition to our Vista pilot clinic located in the state of WA.

 >> Read Full Release